Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.320 +0.190 (+3.10%)

Streaming Delayed Price Updated: 10:07 AM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? ↗

September 05, 2024

Could this beaten-down stock turn things around in the near future?

Via The Motley Fool

2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock ↗

September 03, 2024

The risks may resolve in a year or so but seizing the opportunities will take longer.

Via The Motley Fool

This 1 AI Stock Could Revolutionize Biotech and Pharma ↗

September 02, 2024

The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.

Via The Motley Fool

Topics Artificial Intelligence

From Promise to Peril: The Downfall of Ginkgo Bioworks ↗

August 26, 2024

Via Benzinga

Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock? ↗

August 24, 2024

Its ambitious business model may not be sustainable.

Via The Motley Fool

Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? ↗

August 15, 2024

Have shares of the troubled life sciences business fallen too far?

Via The Motley Fool

Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks ↗

August 13, 2024

Efficiency in core processes is set to increase substantially due to AI.

Via The Motley Fool

Topics Artificial Intelligence

DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split ↗

August 02, 2024

Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.

Via InvestorPlace

7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money? ↗

July 23, 2024

Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see.

Via InvestorPlace

7 Sorry Biotech Stocks Set to Make Investors Sad ↗

July 22, 2024

Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.

Via InvestorPlace

AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy ↗

July 18, 2024

Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up.

Via InvestorPlace

Topics Artificial Intelligence

DNA Stock: Ginkgo Bioworks Announces New Collaboration ↗

July 16, 2024

Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges.

Via InvestorPlace

Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy? ↗

July 14, 2024

A recovery plan is underway, but it isn't a slam dunk.

Via The Motley Fool

3 Stocks to Avoid Like the Plague in 2024 ↗

July 11, 2024

Avoid these three stocks like the plague in 2024 to protect your portfolio from potential pitfalls and losses.

Via InvestorPlace

3 High-Risk, Sky-High Reward Stocks to Buy for Under $1 ↗

July 10, 2024

These high-risk penny stocks may be cheap, but their low per-share pricing conceals unique tailwinds that could propel them higher.

Via InvestorPlace

Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted ↗

July 10, 2024

Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat.

Via InvestorPlace

7 F-Rated Stocks To Sell in July ↗

July 08, 2024

If you're going to outperform even a basic index fund this year, you need to identify any F-rated stocks to sell in July.

Via InvestorPlace

3 Biotech Stocks to Sell in July Before They Crash & Burn ↗

July 05, 2024

While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late

Via InvestorPlace

Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally ↗

July 03, 2024

Via Benzinga

Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich ↗

June 27, 2024

These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.

Via InvestorPlace

Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump ↗

June 26, 2024

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market.

Via Benzinga

Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts ↗

June 26, 2024

Perion Network layoffs are a hot topic on Wednesday as the company announces plans to cut 35 jobs its in search division due to Bing changes.

Via InvestorPlace

Topics Workforce

Ginkgo Bioworks Layoffs Expand to 400 Job Cuts ↗

June 26, 2024

Ginkgo Bioworks layoffs are coming for 400 of the company's employees as it seeks to reduce labor costs as part of a restructuring.

Via InvestorPlace

Topics Workforce

Why Ginkgo Bioworks Stock Is Sinking Today ↗

June 26, 2024

There was double trouble for this beaten-down biotech stock.

Via The Motley Fool

Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival ↗

June 25, 2024

Via Benzinga

ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday ↗

June 24, 2024

Via Benzinga

Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears ↗

June 24, 2024

A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees.

Via InvestorPlace

Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts ↗

June 24, 2024

Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week.

Via InvestorPlace

Topics Workforce

5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains ↗

June 20, 2024

Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.